Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Cooper

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Annals of Emergency Medicine|June 1, 1989
Complications and protocol considerations in carbon monoxide-poisoned patients who require hyperbaric oxygen therapy: report from a ten-year experienceE P Sloan, D G Murphy, R Hart, et al.
Annals of Emergency Medicine|May 1, 1988
Emergency department screening for unsuspected carbon monoxide exposureT L Turnbull, R G Hart, G R Strange, et al.
Biochemical Society Transactions|October 21, 2006
Novel structural determinants of single-channel conductance in nicotinic acetylcholine and 5-hydroxytryptamine type-3 receptorsJ A Peters, J E Carland, M A Cooper, et al.
Acta Virologica|September 12, 2013
Molecular characterization of the receptor binding structure-activity relationships of influenza B virus hemagglutininV Carbone, H Kim, J X Huang, et al.
Poultry Science|March 29, 2000
Ascites syndrome and related pathologies in feed restricted broilers raised in a hypobaric chamberJ M Balog, N B Anthony, M A Cooper, et al.
Cytometry|December 18, 2001
Effects of antibody concentration on the separation of human natural killer cells in a commercial immunomagnetic separation systemK Comella, M Nakamura, K Melnik, et al.
Blood|May 9, 2001
Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subsetM A Cooper, T A Fehniger, S C Turner, et al.
Disease-A-Month : DM|January 27, 1998
Environmental injuriesJ B Leikin, S E Aks, S Andrews, et al.
The Journal of Clinical Investigation|July 6, 2000
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapyT A Fehniger, E M Bluman, M M Porter, et al.
British Journal of Pharmacology|May 14, 2014
Pathway-selective antagonism of proteinase activated receptor 2J Y Suen, A Cotterell, R J Lohman, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Annals of Emergency Medicine|June 1, 1989
Complications and protocol considerations in carbon monoxide-poisoned patients who require hyperbaric oxygen therapy: report from a ten-year experienceE P Sloan, D G Murphy, R Hart, et al.
Annals of Emergency Medicine|May 1, 1988
Emergency department screening for unsuspected carbon monoxide exposureT L Turnbull, R G Hart, G R Strange, et al.
Biochemical Society Transactions|October 21, 2006
Novel structural determinants of single-channel conductance in nicotinic acetylcholine and 5-hydroxytryptamine type-3 receptorsJ A Peters, J E Carland, M A Cooper, et al.
Acta Virologica|September 12, 2013
Molecular characterization of the receptor binding structure-activity relationships of influenza B virus hemagglutininV Carbone, H Kim, J X Huang, et al.
Poultry Science|March 29, 2000
Ascites syndrome and related pathologies in feed restricted broilers raised in a hypobaric chamberJ M Balog, N B Anthony, M A Cooper, et al.
Cytometry|December 18, 2001
Effects of antibody concentration on the separation of human natural killer cells in a commercial immunomagnetic separation systemK Comella, M Nakamura, K Melnik, et al.
Blood|May 9, 2001
Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subsetM A Cooper, T A Fehniger, S C Turner, et al.
Disease-A-Month : DM|January 27, 1998
Environmental injuriesJ B Leikin, S E Aks, S Andrews, et al.
The Journal of Clinical Investigation|July 6, 2000
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapyT A Fehniger, E M Bluman, M M Porter, et al.
British Journal of Pharmacology|May 14, 2014
Pathway-selective antagonism of proteinase activated receptor 2J Y Suen, A Cotterell, R J Lohman, et al.
Pageof 13